全文获取类型
收费全文 | 682篇 |
免费 | 51篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 17篇 |
妇产科学 | 9篇 |
基础医学 | 67篇 |
口腔科学 | 7篇 |
临床医学 | 65篇 |
内科学 | 107篇 |
皮肤病学 | 7篇 |
神经病学 | 34篇 |
特种医学 | 115篇 |
外科学 | 184篇 |
综合类 | 17篇 |
预防医学 | 22篇 |
眼科学 | 32篇 |
药学 | 52篇 |
肿瘤学 | 13篇 |
出版年
2023年 | 5篇 |
2021年 | 10篇 |
2020年 | 10篇 |
2019年 | 10篇 |
2018年 | 12篇 |
2017年 | 7篇 |
2016年 | 6篇 |
2015年 | 9篇 |
2014年 | 11篇 |
2013年 | 26篇 |
2012年 | 15篇 |
2011年 | 21篇 |
2010年 | 19篇 |
2009年 | 23篇 |
2008年 | 23篇 |
2007年 | 37篇 |
2006年 | 27篇 |
2005年 | 27篇 |
2004年 | 12篇 |
2003年 | 10篇 |
2002年 | 16篇 |
2001年 | 28篇 |
2000年 | 19篇 |
1999年 | 20篇 |
1998年 | 23篇 |
1997年 | 20篇 |
1996年 | 29篇 |
1995年 | 18篇 |
1994年 | 11篇 |
1993年 | 8篇 |
1992年 | 15篇 |
1991年 | 12篇 |
1990年 | 9篇 |
1989年 | 19篇 |
1988年 | 32篇 |
1987年 | 22篇 |
1986年 | 16篇 |
1985年 | 22篇 |
1984年 | 13篇 |
1983年 | 7篇 |
1982年 | 5篇 |
1981年 | 8篇 |
1980年 | 5篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 6篇 |
1973年 | 4篇 |
1970年 | 6篇 |
1968年 | 5篇 |
1966年 | 3篇 |
排序方式: 共有750条查询结果,搜索用时 1 毫秒
21.
22.
Marian G. Michaels Ricardo M. La Hoz Lara Danziger-Isakov Emily A. Blumberg Deepali Kumar Michael Green Timothy L. Pruett Cameron R. Wolfe 《American journal of transplantation》2020,20(7):1768-1772
The recent identification of an outbreak of 2019‐ novel Coronavirus is currently evolving, and the impact on transplantation is unknown. However, it is imperative that we anticipate the potential impact on the transplant community in order to avert severe consequences of this infection on both the transplant community and contacts of transplant patients. 相似文献
23.
Yoshihide Nanno Joshua J. Wilhelm David Heller Robben Schat Martin L. Freeman Guru Trikudanathan Varvara A. Kirchner Timothy L. Pruett Gregory J. Beilman Bernhard J. Hering Melena D. Bellin 《Clinical transplantation》2020,34(8):e14008
Islet yield is an important predictor of acceptable glucose control after total pancreatectomy with islet autotransplantation (TP-IAT). We assessed if pancreas volume calculated with preoperative MRI could assess islet yield and postoperative outcomes. We reviewed dynamic MRI studies from 154 adult TP-IAT patients (2009-2016), and associations between calculated volumes and digest islet equivalents (IEQs) were tested. In multivariate regression analysis, pancreas volume (P < .001) and preoperative HbA1c levels (P = .009) were independently associated with digest IEQs. The IEQ prediction formula was calculated according to each preoperative HbA1c level, (a) pancreas volume × 5800 for HbA1c ≥ 6.5, (b) pancreas volume × 10 000 for HbA1c ≥5.7/<6.5 and (iii) pancreas volume × 11 400 for HbA1c < 5.7. The formula was internally validated with 28 TP-IAT patients between 2017 and 2018 (r2 = .657 and r2 = .710 when restricted to 24 patients without prior pancreatectomy). An estimated IEQs/Body Weight (kg) ≥3700 predicted HbA1c ≤6.5 and insulin independence at 1 year after TP-IAT with 77% and 88% sensitivity and 55% and 43% specificity, respectively. The combination of pancreas volume and preoperative HbA1c levels may be useful to estimate islet yield. Estimated IEQs were reasonably sensitive to predict acceptable glucose control at 1 year. 相似文献
24.
25.
Melena D. Bellin Maisam Abu-El-Haija Katherine Morgan David Adams Gregory J. Beilman Srinath Chinnakotla Darwin L. Conwell Ty B. Dunn Martin L. Freeman Timothy Gardner Varvara A. Kirchner Luis F. Lara Leslie Long-Simpson Jaimie D. Nathan Bashoo Naziruddin John A. Nyman Timothy L. Pruett Sarah J. Schwarzenberg James S. Hodges 《Pancreatology》2018,18(3):286-290
Background/objectives
Total pancreatectomy with islet autotransplantation (TPIAT) is considered for managing chronic pancreatitis in selected patients when medical and endoscopic interventions have not provided adequate relief from debilitating pain. Although more centers are performing TPIAT, we lack large, multi-center studies to guide decisions about selecting candidates for and timing of TPIAT.Methods
Multiple centers across the United States (9 to date) performing TPIAT are prospectively enrolling patients undergoing TPIAT for chronic pancreatitis into the Prospective Observational Study of TPIAT (POST), a NIDDK funded study with a goal of accruing 450 TPIAT recipients. Baseline data include participant phenotype, pancreatitis history, and medical/psychological comorbidities from medical records, participant interview, and participant self-report (Medical Outcomes Survey Short Form-12, EQ-5D, andPROMIS inventories for pain interference, depression, and anxiety). Outcome measures are collected to at least 1 year after TPIAT, including the same participant questionnaires, visual analog pain scale, pain interference scores, opioid requirements, insulin requirements, islet graft function, and hemoglobin A1c. Health resource utilization data are collected for a cost-effectiveness analysis. Biorepository specimens including urine, serum/plasma, genetic material (saliva and blood), and pancreas tissue are collected for future study.Conclusions
This ongoing multicenter research study will enroll and follow TPIAT recipients, aiming to evaluate patient selection and timing for TPIAT to optimize pain relief, quality of life, and diabetes outcomes, and to measure the procedure's cost-effectiveness. A biorepository is also established for future ancillary studies. 相似文献26.
An inhibitory monoclonal antibody to factor X that blocks prothrombin activation but not prothrombinase enzyme assembly 总被引:1,自引:0,他引:1
A monoclonal antibody (designated alpha BFX-2b) prepared against bovine factor X inhibited factor X activity in human, bovine, porcine, rabbit, and canine plasma. In assays using purified prothrombinase components, factor Xa, factor Va, phospholipid vesicles, and calcium ion with the fluorescent active site thrombin inhibitor dansylarginyl-N-(3-ethyl-1,5- pentanediyl)amide, the antibody inhibited the conversion of prothrombin to thrombin. Antibody alpha BFX-2b also blocked prothrombinase cleavage of the macromolecular substrates prethrombin 1 and prethrombin 2 but did not inhibit factor Xa hydrolysis of the synthetic substrate benzoyl- Ile-Glu-Gly-Arg-p-nitroanilide. The antibody also prevented the inactivation of factor Xa by antithrombin III but did not prevent the inactivation by soybean trypsin inhibitor. Antibody alpha BFX-2b bound factor Xa with a stoichiometry of 1:1 and an apparent dissociation constant of 9.0 x 10(-11) mol/L as estimated from its inhibition of prothrombinase activity. Antibody alpha BFX-2b did not prevent binding of factor Xa to factor Va-phospholipid as measured by using fluorescence polarization or high-pressure liquid gel chromatography with the fluorescent Factor Xa analogue dansyl-glutamyl-glycyl-arginyl- Xa. Immunoblotting of factor X following electrophoresis on sodium dodecyl sulphate-polyacrylamide gels and transfer to nitrocellulose indicated that the antigenic determinant recognized by antibody alpha BFX-2b was found on the heavy chain of factors X and Xa. From these observations it can be concluded that antibody alpha BFX-2b recognizes a highly conserved epitope on the factor X heavy chain that is remote from the topographic sites required for prothrombinase complex assembly and substrate hydrolysis but may be located at or near a portion of the macromolecular substrate binding site. 相似文献
27.
Oren Ledder Wolfram Haller Richard TL Couper Peter Lewindon Mark Oliver 《Journal of gastroenterology and hepatology》2014,29(12):1954-1962
This paper, the second in the series, will build on the first and explore the importance of liver and pancreatic manifestations of cystic fibrosis (CF) and the effect on morbidity and mortality of this multifaceted genetic condition. It will also further develop the critical role of the gastroenterologist as part of the multidisciplinary group of clinicians and allied health staff in the effective management of patients with CF. 相似文献
28.
S B Pruett J E Chambers H W Chambers 《International journal of immunopharmacology》1989,11(4):385-393
In the course of immunotoxicological studies of several organophosphorous compounds, it was noted that some phenylphosphonothioates enhanced the activation of rat splenocytes by concanavalin A. In the present study some of these compounds were compared to the well-characterized immunomodulatory thiol, 2-mercaptoethanol (2-ME). Two of the compounds are able to substitute for 2-ME and allow near maximal growth of a strictly 2-ME-dependent lymphocyte cell line (CTLL-2). These compounds exhibit essentially additive effects with 2-ME on CTLL-2 cells and rat splenocytes. In agreement with previous results with 2-ME, the phosphonothioates have essentially no effect on interleukin-2 production in mitogen-stimulated splenocyte cultures. One phosphonothioate, as well as its possible thiol hydrolysis product, supports cell survival and enhanced cystine incorporation by CTLL-2 cells. However, 2-ME was more effective in stimulation of enhanced generation of extracellular thiols than were the other agents. These results suggest very similar modes of action for phosphonothionates and 2-ME. Finally, a phosphonothioate selected for low neurotoxic potential was examined and found to effectively support lymphocyte growth in vitro and to exhibit relatively low acute toxicity in mice. 相似文献
29.
Pal L; Leykin L; Schifren JL; Isaacson KB; Chang YC; Nikruil N; Chen Z; Toth TL 《Human reproduction (Oxford, England)》1998,13(7):1837-1840
A case series of eight cycles of in-vitro fertilization (IVF) in five women
diagnosed with malignant disorders is presented. These patients chose to
defer definitive treatment for a chance for preservation of potential
fertility. The response of these patients to ovarian stimulation, and the
outcome, was compared with 17 IVF cycles in 12 age- matched patients with
isolated tubal infertility. An apparent adverse influence of malignant
disease on the quality and behaviour of oocytes was observed. Despite a
comparable total number of oocytes per cycle in the two groups, a
significantly reduced percentage of mature oocytes was retrieved per cycle
from patients with malignant diseases. The oocytes from patients with
malignant disorders were of a poorer quality and exhibited a significantly
impaired fertilization rate compared to the controls. We propose that
neoplastic processes, irrespective of the site or cell of origin, may have
a detrimental impact on the biology of oocytes, an effect akin to that seen
on spermatozoa in men with certain malignancies.
相似文献
30.
Holyoake TL; Freshney MG; McNair L; Parker AN; McKay PJ; Steward WP; Fitzsimons E; Graham GJ; Pragnell IB 《Blood》1996,87(11):4589-4595
The characterization of many cytokines involved in the control of hematopoiesis has led to intense investigation into their potential use in ex vivo culture to expand progenitor numbers. We have established the optimum ex vivo culture conditions that allow substantial amplification of transient engrafting murine stem cells and which, simultaneously, augment the ability to sustain serial bone marrow transplantation (BMT). Short-term incubation of unfractionated BM cells in liquid culture with stem cell factor (SCF) and interleukin-11 (IL- 11) produced a 50-fold amplification of clonogenic multipotential progenitors (CFU-A). Following such ex vivo expansion, substantially fewer cells were required to rescue lethally irradiated mice. When transplanted in cell doses above threshold for engraftment, BM cells expanded ex vivo resulted in significantly more rapid hematopoietic recovery. In a serial transplantation model, unmanipulated BM was only able to consistently sustain secondary BMT recipients, but BM expanded ex vivo has sustained quaternary BMT recipients that remain alive and well more than 140 days after 4th degree BMT. These results show augmentation of both short-term recovery posttransplant and the ability to serially transplant marrow by preincubation in culture with SCF and IL-11. 相似文献